Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disease Patients with Long Duration and Low Disease Activity
收藏Mendeley Data2024-01-31 更新2024-06-26 收录
下载链接：
https://data.mendeley.com/datasets/x38yzs6cd3
下载链接
链接失效反馈官方服务：
资源简介：
SUPPLEMENT Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disease Patients with Long Duration and Low Disease Activity: A Randomised Double-Masked, Placebo-controlled, Multicenter Trial Raymond S. Douglas et al
补充材料：特雷普妥单抗（Teprotumumab）治疗病程较长且疾病活动度较低的甲状腺眼病（Thyroid Eye Disease）患者的疗效与安全性：一项随机双盲、安慰剂对照多中心试验 雷蒙德·S·道格拉斯（Raymond S. Douglas）等人
创建时间：
2024-01-31
